MCSTAP Case Discussion Series: Discussions in Complicated Practice: Tricky Urine Test Results - September 17, 2025

This site is for learners who attended the live September 17, 2025, program to claim credit.

Claiming Credit 

Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.

ADA statement: To request reasonable accommodations for a disability please contact [email protected], in writing, at least two weeks prior to the activity.

Target Audience

Primary care physicians, internists, family practice physicians, nurse practitioners, nurses, and physician assistants

Learning Objectives

Upon completion of this activity, participants will be able to:
  • Interpret unexpected urine toxicology results for patients stable on medications for opioid use disorder (MOUD), differentiating between true positives, false positives, and possible contamination.
  • Assess each case scenario by integrating the patient’s history, plausibility of the clinical story, and confirmatory testing results to establish an accurate working diagnosis.
  • Formulate a patient-centered management plan that considers the stage of substance use disorder, the patient’s medical and psychosocial stability, and safety priorities.
  • Demonstrate effective, nonjudgmental communication strategies to negotiate next steps with the patient, establish follow-up intervals, and ensure ongoing engagement in care.

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Opioid Education Statement
  • 1.00 Participation
Course opens: 
09/17/2025
Course expires: 
11/18/2025
Rating: 
0
Zoom
United States
Christopher Shanahan, MD, MPH, FACP
MCSTAP Medical Director, CME Course Director
 
 
 
BU CCE Operations Manager: Naomi Moeller

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1 hour of opioid education.

 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Opioid Education Statement
  • 1.00 Participation
Please login or register to take this course.